Endocrinology
Metabolic Syndrome
More in Metabolic Syndrome
News and commentary from the endocrinology world
Participants also had improved cardiometabolic measures with Epitomee device
Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist
Diagnoses were also delayed the longer sugar was restricted
News and commentary from the endocrinology world
Remission of coexisting conditions was also maintained, long-term data show
However, 24 weeks of the GLP-1 had no impact on eGFR
Findings leave researcher "concerned"
News and commentary from the endocrinology world
News and commentary from the endocrinology world
Also in TTHealthWatch: menopause hormone therapy in the U.S.
News and commentary from the endocrinology world
Benefit in symptoms, functional outcomes remains to be seen for HU6
News and commentary from the endocrinology world
